In September 2004, the University of Hong Kong Spinal Cord Injury Fund (HKU-SCI Fund) was born, and the China Spinal Cord Injury Network (ChinaSCINet) was also established in partnership with the HKU-SCI Fund.  Out of this collaboration, in June 2006, two non-profit companies, the China Spinal Cord Injury Network (ChinaSCINet) Company Limited and the Hong Kong Spinal Cord Injury Fund (HKSCIFund) Limited (formerly the ‘HKU-SCI Fund’), were established. They are dedicated to running the clinical trials and to raising funds for the trials respectively.  

The HKSCIFund Ltd. is a registered charitable organization in Hong Kong (Registered Charity Number: 918370).  The sole function of the HKSCIFund is to support the ChinaSCINet.

The China Spinal Cord Injury Network is the largest spinal cord injury clinical trial network in the world, comprising more than 20 leading spinal cord injury centers in Mainland China, Hong Kong and Taiwan. It has been established to develop and test the most promising therapies for spinal cord injury and aims at accelerating movement of therapies from laboratory to clinic.